|
Jul 25
|
European Equities Traded in the US as American Depositary Receipts Lower in Friday Trading; Gain 1.6% for Week
|
|
Jul 24
|
European Equities Traded in the US as American Depositary Receipts Rise Slightly in Thursday Trading
|
|
Jul 22
|
European Equities Traded in the US as American Depositary Receipts Rise in Tuesday Trading
|
|
Jul 18
|
European Equities Traded in the US as American Depositary Receipts Edge Higher in Friday Trading
|
|
Jul 17
|
European Equities Traded in the US as American Depositary Receipts Trend Lower in Thursday Trading
|
|
Jul 16
|
European Equities Traded in the US as American Depositary Receipts Decline in Wednesday Trading
|
|
Jul 15
|
European Equities Traded in the US as American Depositary Receipts Lower in Tuesday Trading
|
|
Jun 26
|
European Equities Traded in the US as American Depositary Receipts Higher in Thursday Trading
|
|
Jun 12
|
High Growth Tech Stocks In Europe To Watch June 2025
|
|
Jan 2
|
Exploring Three High Growth Tech Stocks For Future Potential
|
|
Jul 30
|
Grifols Cuts Chinese Stake Value by €457 Million After Audit
|
|
Jul 29
|
Grifols receives expanded XEMBIFY® (immune globulin subcutaneous human-klhw) label in U.S., strengthening its Ig portfolio for patients
|
|
Jun 18
|
Grifols completes sale of a 20% equity stake in SRAAS and forges strategic alliance with Haier Group
|
|
Jun 17
|
Biotest wins FDA approval for plasma protein therapy
|
|
Jun 17
|
Grifols prepares for late-stage plans with plasma-derived medicines in 2024
|
|
Jun 17
|
Grifols’ Biotest receives FDA approval for innovative Yimmugo® immunoglobulin to treat primary immunodeficiencies
|
|
Feb 14
|
GRFS or ZTS: Which Is the Better Value Stock Right Now?
|
|
Feb 14
|
Grifols announces positive topline phase 3 fibrinogen clinical trial results
|
|
Jan 15
|
Here's Why Grifols (GRFS) is Poised for a Turnaround After Losing -31.55% in 4 Weeks
|
|
Jan 14
|
Grifols Says Haier Has Offered Reassurance on China Deal
|